Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
What were the outcomes of critical catalysts featured in Biomedtracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free.
This vital infographic contains critical data about Golodirsen for Duchenne Muscular Dystrophy (DMD), Recarbrio for Intra-Abdominal Infections, and Recarbrio for Urinary Tract and Reproductive Tract Infections, including:
• The catalyst that occurred
• Trial results
• Biomedtracker’s Likelihood of Approval (LOA) analysis
• 5-day stock performance surrounding the catalyst event
• Other notable upcoming catalysts for the drugs
• Reactions from SAGE and Aevi Genomic
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
